Partnership to Improve Patient Care

  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Engage with CMS
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • PIPC Newsroom
    • Press Releases
    • PIPC in the News
    • PIPC Weekly Update
    • PIPC Patients' Blog
    • Chairman's Corner
    • The Data Mine
  • Events
    • Nevada AB 259
    • QALY Panel
    • QALY Briefing
    • Past Webinars >
      • MFN/IPI Webinar 2025
      • Discrimination & Health Care
      • C & GT Webinar
      • ICER COVID Webinar
      • Value Our Health Briefing
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Engage with CMS
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • PIPC Newsroom
    • Press Releases
    • PIPC in the News
    • PIPC Weekly Update
    • PIPC Patients' Blog
    • Chairman's Corner
    • The Data Mine
  • Events
    • Nevada AB 259
    • QALY Panel
    • QALY Briefing
    • Past Webinars >
      • MFN/IPI Webinar 2025
      • Discrimination & Health Care
      • C & GT Webinar
      • ICER COVID Webinar
      • Value Our Health Briefing
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010

The PIPC Newsroom

PIPC Weekly Update: October 19, 2026

10/19/2026

 
In this week's edition...
 
—AJMC: UPL’s Present a Risk for Patients, Pharmacies and Providers. View the article here.
— Personalized Medicine Coalition Conference November 18-19. Register to attend here.
— Bipartisan Resolution Marking the 27th Anniversary of the Landmark Supreme Court Decision, Olmstead v. L.C. See details below. 
— Beyond A Seat At The Table: Meaningful Patient Representation On Pharmacy And Therapeutics Committees. View the article here. View PIPC’s 2024 comment here. 
— CMS Finalizes GLOBE Model, PIPC Opposes Importing QALYS. View the full statement here. Share concerns on X here and on LinkedIn here. 
— USPSTF Changes Imply a Shift Toward Consideration of Cost Effectiveness. View the Inside Health Policy article here ($). View the AcademyHealth statement here. 
— Legacy HTA: Deconstructing the Impossible QALY. View the Class Notes here.
— PCORI Seeking Input on Research Priorities. Click here to submit your ideas by Nov. 2.
— Join IVI for 2026 Whole Health Policy Summit in November. Learn more here. Register to attend in person here. Register to attend the livestream here. 
— ICHOM Advances the Spinal Muscular Atrophy Patient Validation Survey, Plus Annual Conference December 7-9. Complete the Patient Validation Survey here and register for the conference here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: September 28, 2026

9/28/2026

 
In this week's edition...

-- MFN Policies Limit Patients’ Ability to Access Treatments that Work Best for Them. As lawmakers continue to explore most favored nation pricing, they must listen to patients like Crystal.
-- USPSTF Changes Imply a Shift Toward Consideration of Cost Effectiveness. View the Inside Health Policy article here ($). View the AcademyHealth statement here. 
-- Ruling Vacating Community Integration Provisions in 2024 Section 504 Rule. View the AAPD statement here. Learn more about the DCIC here.
-- Maryland Matters: The Danger of PDABs for Patients. Read a recent opinion piece, Gone from the shelf: The hidden danger of drug price caps, here.
-- Legacy HTA: Deconstructing the Impossible QALY. View the Class Notes here.
-- 86 Organizations Comment to Senate Finance Committee, Oppose Importing QALYs, Urge Decisions Centered on Patients and People with Disabilities. View the RFI comments here.
-- New Research Highlights Gaps in Use of CER and Patient Experience. View PIPC's Data Mine Blog analysis here and a recent Value in Health article here.
-- PCORI Seeking Input on Research Priorities. Click here to submit your ideas by Nov. 2.
-- PIPC Submits IPAY 2028 Comments to CMS. View the IPAY 2028 comments to CMS here.
-- Washington Examiner: Review of Implications of Germany, Foreign Drug Prices. Read the Washington Examiner article here.
-- As the ADA Turns 36, PIPC Highlights Work to be Done. Learn More About How the QALY Devalues Disabled Lives. View examples of QALY health utilities that assign a lower value to the lives of people with disabilities here.
-- Join IVI for 2026 Whole Health Policy Summit in November. Learn more here. Register to attend in person here. Register to attend the livestream here. 
-- ICHOM Seeking Experts in Cataracts, Plus Annual Conference December 7-9. Register here!
-- ICHOM Advances the Spinal Muscular Atrophy Patient Validation Survey. Complete the Patient Validation Survey here.
— PCORI Annual Meeting October 19-20. Click here to register.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: September 21, 2026

9/21/2026

 
In this week's edition...
 
— 86 Organizations Comment to Senate Finance Committee, Oppose Importing QALYs, Urge Decisions Centered on Patients and People with Disabilities. View the RFI comments here.
— New Research Highlights Gaps in Use of CER and Patient Experience. View PIPC's Data Mine Blog analysis here and a recent Value in Health article here.
— PCORI Seeking Input on Research Priorities. Click here to submit your ideas by Nov. 2.
— PIPC Submits IPAY 2028 Comments to CMS. View the IPAY 2028 comments to CMS here.
— Washington Examiner: Review of Implications of Germany, Foreign Drug Prices. Read the Washington Examiner article here.
— As the ADA Turns 36, PIPC Highlights Work to be Done. Learn More About How the QALY Devalues Disabled Lives. View examples of QALY health utilities that assign a lower value to the lives of people with disabilities here.
— MFN Policies Limit Patients’ Ability to Access Treatments that Work Best for Them. We must not import access restrictions that devalue people living with rare diseases.
— 100 Members of Congress call on DOJ To Rescind Olmstead Memo. View the letter here. View a message from Senator Kirsten Gillibrand here.
— Join IVI for 2026 Whole Health Policy Summit in November. Learn more here. Register to attend in person here. Register to attend the livestream here. 
— ICHOM Seeking Experts in Cataracts, Plus Annual Conference December 7-9. Register here!
— ICHOM Advances the Spinal Muscular Atrophy Patient Validation Survey. Complete the Patient Validation Survey here.
— PCORI Annual Meeting October 19-20. Click here to register.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: September 8, 2026

9/8/2026

 
In this week's edition...
 
— 86 Organizations Comment to Senate Finance Committee, Oppose Importing QALYs, Urge Decisions Centered on Patients and People with Disabilities. View the RFI comments here.
— PIPC Conducts New Research on Use of Evidence Centered on Patient Experience in Medicare Drug Price Negotiation, Submits IPAY 2028 Comments to CMS. View PIPC's Data Mine Blog analysis here and the IPAY 2028 comments to CMS here.
— As the ADA Turns 36, PIPC Highlights Work to be Done. Learn More About How the QALY Devalues Disabled Lives. View examples of QALY health utilities that assign a lower value to the lives of people with disabilities here.
— MFN Policies Limit Patients’ Ability to Access Treatments that Work Best for Them. We must not import access restrictions that devalue people living with rare diseases.
— 100 Members of Congress call on DOJ To Rescind Olmstead Memo. View the letter here. View a message from Senator Kirsten Gillibrand here.
— ICHOM Seeking Experts in Cataracts, Plus Annual Conference December 7-9. Register here!
— PCORI Annual Meeting October 19-20. Click here to register.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: August 24, 2026

8/24/2026

 
In this week's edition...
 
— 86 Organizations Comment to Senate Finance Committee, Oppose Importing QALYs, Urge Decisions Centered on Patients and People with Disabilities. View the RFI comments here.
— PIPC Conducts New Research on Use of Evidence Centered on Patient Experience in Medicare Drug Price Negotiation, Submits IPAY 2028 Comments to CMS. View PIPC's Data Mine Blog analysis here and the IPAY 2028 comments to CMS here.
— As the ADA Turns 36, PIPC Highlights Work to be Done. Learn More About How the QALY Devalues Disabled Lives. View examples of QALY health utilities that assign a lower value to the lives of people with disabilities here.
— MFN Policies Limit Patients’ Ability to Access Treatments that Work Best for Them. We must not import access restrictions that devalue people living with rare diseases.
— 100 Members of Congress call on DOJ To Rescind Olmstead Memo. View the letter here. View a message from Senator Kirsten Gillibrand here.
— ICHOM Seeking Experts in Cataracts, Plus Annual Conference December 7-9. Register here!
— PCORI Annual Meeting October 19-20. Click here to register.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: July 27, 2026

7/27/2026

 
In this week's edition...
 
— QALYs Devalue the Lives of People with Disabilities. View examples of QALY health utilities that assign a lower value to the lives of people with disabilities here.
— MFN Policies Limit Patients’ Ability to Access Treatments that Work Best for Them. We must not import access restrictions that devalue people living with rare diseases.
— Disability Matters with Joyce Bender: PIPC Chairman Tony Coelho and Rep. Steny Hoyer. Listen to the podcast here.
— PCORI Annual Meeting October 19-20. Click here to register.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— The Disability Community Voices Concern About Recent DOJ Memorandum. Learn more HERE and HERE.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: July 20, 2026

7/20/2026

 
In this week's edition...
 
— MFN Policies Limit Patients’ Ability to Access Treatments that Work Best for Them. We must not import access restrictions that devalue people living with rare diseases.
— Disability Matters with Joyce Bender: PIPC Chairman Tony Coelho and Rep. Steny Hoyer. Listen to the podcast here.
— PCORI Annual Meeting October 19-20. Click here to register.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— Atlantic: How Britain Became As Poor As Mississippi. View the article here.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— The Disability Community Voices Concern About Recent DOJ Memorandum. Learn more HERE and HERE.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below

Read More

PIPC Weekly Update: July 6, 2026

7/6/2026

 
In this week's edition...
 
— Advocates Request Changes to the VA National Formulary Act of 2025. View the letter here.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— The Disability Community Voices Concern About Recent DOJ Memorandum. Learn more HERE and HERE.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: June 29, 2026

6/29/2026

 
In this week's edition...
 
— Advocates Request Changes to the VA National Formulary Act of 2025. View the letter here.
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— DOJ Attacks the Americans with Disabilities Act and Section 504 Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. Learn more HERE and HERE.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: June 22, 2026

6/22/2026

 
— Senator Collins Speaks Up Against Importing QALYs to the U.S., Committee Advances Charlotte’s Bill. The video is available on LinkedIn here and on X here. We encourage others to share PIPC’s social media thanking the Senator on LinkedIn here and on X here. Hear Charlotte herself describe this terrific progress here.
— DOJ Attacks the Americans with Disabilities Act and Section 504 Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. Learn more HERE and HERE.
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: June 15, 2026

6/15/2026

 
In this week's edition...
 
— AMA Opposes Policies Setting Prices by Exclusive Reference to Other Countries or Averages. View the resolution here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— States Attack Section 504 of the Rehabilitation Act and the Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. View the Arc of Indiana press release HERE. Learn more HERE about how state advocates can push back.
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: June 8, 2026

6/8/2026

 
In this week's edition...
 
— House Appropriations Bill Seeks to Rescind PCORI Funds. View section 530 here. Learn more about PCORI here.
— Tell Congress to Oppose Most Favored Nation Policies Importing QALYs to the U.S. Learn more here. Reach out to your Member of Congress here. 
— States Attack Section 504 of the Rehabilitation Act and the Integration Mandate, Impact on People with Disabilities, Rare Diseases and Older Adults Massive. View the Arc of Indiana press release HERE. Learn more HERE about how state advocates can push back.
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: May 26, 2026

5/26/2026

 
In this week's edition...
 
— PIPC Chairman Tony Coelho Publishes Statement on VA PDAB Bills. PIPC Chairman Tony Coelho issued a statement on the vetoes of ​HB 483 and SB 271 in Virginia.
— Ohioans Oppose MFN Drug Pricing Due to Risks for Rural and Disability Communities. Click here to view Margaret Ann Ruhl's piece and click here to view Pandora Shaw-Dupras' piece.
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Indiana Withdraws from Attack on Section 504 of the Rehabilitation Act and the Integration Mandate. View the Arc of Indiana press release HERE. Learn more HERE about how state advocates are pushing back.
— Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
— Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
— Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Michigan Seeks to Incorporate QALYs into Appropriations Bill. View the letters HERE. 
— Patients and People with Disabilities Urge Policymakers to Reject Importing Foreign Drug Pricing Policies. View PIPC’s response to the SOTU here. View the letters from 119 organizations to CMS commenting on the GLOBE and GUARD models here. View the blog here. Learn more about the implications of importing QALYs here.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: May 18, 2026

5/18/2026

 
In this week's edition...

— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
-- PIPC Provides Additional Comments to Minnesota PDAB. View the PIPC letter here.
-- PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
-- Indiana Withdraws from Attack on Section 504 of the Rehabilitation Act and the Integration Mandate. View the Arc of Indiana press release HERE. Learn more HERE about how state advocates are pushing back.
-- Accessible Healthcare for People with Disabilities: An Implementation Guide for Healthcare Organizations. View and share the resource HERE.
-- Liver Disease Set of Patient-Centered Outcome Measures. To learn more about this project, please visit the website here. You can share the patient survey here.
-- Most-Favored-Nation (MFN) Drug Pricing: You Can’t Import European Prices Without Importing European Tradeoffs. View and share HERE.
-- Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
-- Michigan Seeks to Incorporate QALYs into Appropriations Bill. View the letters HERE. 
— Patients and People with Disabilities Urge Policymakers to Reject Importing Foreign Drug Pricing Policies. View PIPC’s response to the SOTU here. View the letters from 119 organizations to CMS commenting on the GLOBE and GUARD models here. View the blog here. Learn more about the implications of importing QALYs here.
​-- Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More

PIPC Weekly Update: May 4, 2026

5/4/2026

 
In this week's edition...
 
— PIPC Report: The UK Health System, Lessons for the U.S. and the Risks of MFN Drug Pricing. Click here to read the full report.
— Former Members of Congress and Physicians Call Out How MFN Devalues Disabled Lives. View the article here.
— Louisiana Advances Bill to Import QALYs, Advocates Respond. View the Bossier Press-Tribune article here. View the PIPC letter here.
— Michigan Seeks to Incorporate QALYs into Appropriations Bill. View the letters HERE. 
— MFN Policies Devalue Patients, Limiting Treatments for People like Gerry. We must not import access restrictions that devalue people living with chronic illnesses.
— Access at Risk: Innovation for Health Equity in a Time of Uncertainty. Register here.
— Trump Administration Pushes Compliance Deadlines for DOJ's Title II Rule on Digital Accessibility. PIPC will continue to monitor the rule and advocate to ensure that the disabled community does not witness a deterioration in accessibility standards.
— Patients and People with Disabilities Urge Policymakers to Reject Importing Foreign Drug Pricing Policies. View PIPC’s response to the SOTU here. View the letters from 119 organizations to CMS commenting on the GLOBE and GUARD models here. View the blog here. Learn more about the implications of importing QALYs here.
— HEMA Finalizes Report on Economic Evaluation. View PIPC’s critique of the draft report here. View the final report here.
— Devaluing Disabled Lives, International Laws Fall Short of Protecting Equal Access to Health Care for People with Disabilities as Compared to the U.S. View the new Data Mine Blog here.
— Health Affairs Discusses MFN Drug Pricing and QALYs. Click here to read the full article.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

Read More
<<Previous

    Topics

    All
    Alternative Payment Models
    Chairman's Corner
    Patient Centered Research
    PIPC In The News
    PIPC Patient Blog
    PIPC Weekly Update
    Press Releases
    The Data Mine
    Value Frameworks

    Archives

    October 2026
    September 2026
    August 2026
    July 2026
    June 2026
    May 2026
    April 2026
    March 2026
    February 2026
    January 2026
    December 2025
    November 2025
    October 2025
    September 2025
    August 2025
    July 2025
    June 2025
    May 2025
    April 2025
    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    April 2013
    March 2013
    December 2012
    November 2012
    February 2012
    September 2011
    August 2011
    July 2011
    May 2011
    March 2011
    November 2010
    October 2010
    September 2010
    August 2010
    April 2010
    March 2010
    February 2010
    December 2009
    September 2009
    July 2009
    June 2009
    May 2009
    February 2009
    January 2009
    December 2008

Powered by Create your own unique website with customizable templates.